WRBY Warby Parker Inc.
HealthcareAs of 2026-05-26
Valuation
View DetailsP/E (TTM)
1581.15
PEG
14.63
P/B
8.24
P/S
3.46
EV/EBITDA
84.31
DCF Value
$-14.31
FCF Yield
1.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
53.4%
Operating Margin
-0.7%
Net Margin
0.2%
ROE
0.4%
ROA
0.2%
ROIC
-0.6%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $242.4M | $3.2M | $— |
| Q4 null | $212.0M | $-6.0M | $— |
| FY null | $871.9M | $1.6M | $— |
| Q3 null | $221.7M | $5.9M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$30.86
Target (Median)
$32.00
Target Range
$25.00 - $35.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
—
Beta
1.96
Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.